News

trb chemedica develops injectable pharmaceutical products in vouvry

trb chemedica vouvry sa forms the swiss industrial core of the international trb chemedica group, which specializes in the development and manufacture of innovative pharmaceutical products for the treatment of conditions in rheumatology, ophthalmology, and neurology. the vouvry site stands out for its unique expertise in two highly specialized production areas: ganglioside extraction and the manufacture of hyaluronic acid–based injectable products.
TRB Chemedica Fabrique Vouvry Valais Suisse Slider Ordinateur 570×370 FR 768×499 1

SWEETReclaim – a sustainable future for snacks

SWEETReclaim is a project funded by the National Centre for Research and Development. Its aim is to develop snacks made from food industry by-products that support the gut microbiota and help regulate satiety. The Swiss-Polish initiative, focused on sustainable food solutions and carried out under the Polish-Swiss Cooperation Programme, is led by Prof. Anna Michalska-Ciechanowska from the Department of Fruit, Vegetable and Plant Nutraceutical Technology.
1776956015207
Cookie policy
By continuing to browse this site, you agree to the use of cookies to improve your user experience and for the generation of visit statistics. You can customise the use of cookies using the buttons below.
My preferences